Medicare Enrolled
Dr. Javier Gonzalez, MD
Cardiovascular Disease · The Villages, FL
Practice pattern: Remote & Cardiac— Practice combining remote and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gonzalez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gonzalez? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gonzalez
Dr. Javier Gonzalez is a cardiovascular disease in The Villages, FL, with 20 years in practice. Based on federal Medicare data, Dr. Gonzalez performed 12,524 Medicare services across 6,574 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gonzalez received a total of $14,113 from 50 pharmaceutical and/or device companies across 482 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gonzalez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 5% volume in FL$ $14,113 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,524
Medicare services
Top 5% in FL for cardiovascular disease
6,574
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~626 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) | 1,228 | $62 | $179 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,118 | $43 | $237 |
| Office visit, established patient (30-39 min) | 997 | $90 | $254 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 809 | $19 | $56 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 792 | $26 | $141 |
| Remote patient monitoring device, 30 days | 536 | $35 | $95 |
| Remote patient monitoring management, 20 min/month | 500 | $34 | $96 |
| Anticoagulant management of patient taking warfarin | 443 | $8 | $23 |
| Electrocardiogram (EKG), 12-lead | 442 | $10 | $29 |
| Prothrombin time test (blood clotting) | 438 | $4 | $9 |
| Hospital follow-up visit, high complexity | 358 | $94 | $240 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 331 | $50 | $138 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 323 | $87 | $306 |
| Blood draw (venipuncture) | 316 | $8 | $16 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 307 | $313 | $454 |
| Remote pacemaker/defibrillator monitoring, 90 days | 288 | $16 | $43 |
| Echocardiogram, transthoracic | 272 | $144 | $382 |
| Remote pacemaker monitoring, 90 days | 240 | $22 | $60 |
| Comprehensive metabolic blood panel | 220 | $10 | $21 |
| Ultrasound of both sides of head and neck blood flow | 191 | $141 | $372 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 162 | $327 | $846 |
| Hospital follow-up visit, moderate complexity | 162 | $62 | $160 |
| Nuclear medicine study of heart muscle blood flow by pet | 155 | $139 | $445 |
| Lipid panel (cholesterol and triglycerides) | 149 | $13 | $27 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 141 | $2,088 | $5,800 |
| Initial hospital admission, moderate complexity | 117 | $102 | $263 |
| Complete blood count (CBC) with differential | 106 | $8 | $16 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 88 | $138 | $366 |
| New patient office visit (45-59 min) | 87 | $121 | $333 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 82 | $50 | $141 |
| Thyroid stimulating hormone (TSH) test | 74 | $16 | $34 |
| Free thyroxine (T4) test | 72 | $9 | $18 |
| Office visit, established patient (10-19 min) | 65 | $43 | $112 |
| Thyroid hormone, t3 measurement, free | 57 | $17 | $34 |
| Office visit, established patient, complex (40-54 min) | 57 | $135 | $357 |
| Lipoprotein (a) level | 50 | $14 | $29 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 49 | $25 | $73 |
| Ultrasound of leg arteries or artery grafts | 48 | $178 | $465 |
| Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | 46 | $13 | $26 |
| Initial hospital admission, high complexity | 46 | $137 | $350 |
| Insertion of heart rhythm monitor under skin | 42 | $68 | $183 |
| Creatine kinase (cardiac enzyme) level, total | 38 | $6 | $13 |
| Vitamin B-12 level test | 37 | $15 | $30 |
| Folic acid level test | 36 | $14 | $30 |
| Magnesium level test | 36 | $7 | $14 |
| Ferritin level test (iron stores) | 35 | $13 | $27 |
| Iron binding capacity test | 34 | $9 | $18 |
| Iron level test | 33 | $6 | $13 |
| Programming of dual lead pacemaker system | 29 | $54 | $156 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 29 | $85 | $232 |
| Troponin (protein) analysis, quantitative | 27 | $12 | $25 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 23 | $20 | $51 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 23 | $627 | $1,601 |
| Basic metabolic blood panel | 22 | $8 | $17 |
| New patient office visit (30-44 min) | 22 | $72 | $225 |
| Natriuretic peptide (heart and blood vessel protein) level | 21 | $38 | $79 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 14 | $1,159 | $4,156 |
| EKG interpretation and report | 13 | $6 | $16 |
| Heart muscle strain imaging | 13 | $28 | $72 |
| Hospital follow-up visit, low complexity | 13 | $40 | $101 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $16 | $42 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $11 | $28 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.0% high complexity
18.5% medium
74.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,113
Total received (2018-2024)
Avg $2,016/year across 7 years
Top 18% in FL for cardiovascular disease
50
Companies
482
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,644 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$431 (3.1%)
Other
Charitable contributions, space rental, and other categories
$38 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,620
2023$4,261
2022$2,052
2021$1,309
2020$1,678
2019$1,973
2018$1,219
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$2,308
Abbott Laboratories
$1,000
Amgen Inc.
$969
Novartis Pharmaceuticals Corporation
$907
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$824
PFIZER INC.
$780
AstraZeneca Pharmaceuticals LP
$746
Janssen Pharmaceuticals, Inc
$717
SANOFI-AVENTIS U.S. LLC
$659
E.R. Squibb & Sons, L.L.C.
$461
Boehringer Ingelheim Pharmaceuticals, Inc.
$354
Lexicon Pharmaceuticals, Inc.
$325
Medtronic, Inc.
$322
CVRx, Inc.
$316
Merck Sharp & Dohme LLC
$309
Esperion Therapeutics, Inc.
$268
Impulse Dynamics (USA) Inc.
$251
Amarin Pharma Inc.
$230
Biogen, Inc.
$219
Inari Medical, Inc.
$203
Medtronic Vascular, Inc.
$164
BOSTON SCIENTIFIC CORPORATION
$148
Lundbeck LLC
$146
W. L. Gore & Associates, Inc.
$140
Novo Nordisk Inc
$137
SK Life Science, Inc.
$124
Kestra Medical Technology Services, Inc.
$122
Avinger Inc.
$120
Edwards Lifesciences Corporation
$106
Osprey Medical Inc
$101
BIOTRONIK INC.
$91
Astellas Pharma US Inc
$52
Regeneron Healthcare Solutions, Inc.
$51
Merck Sharp & Dohme Corporation
$47
Alnylam Pharmaceuticals Inc.
$46
Welch Allyn
$38
Philips North America LLC
$36
Kowa Pharmaceuticals America, Inc.
$35
Bardy Diagnostics, Inc.
$35
Bayer Healthcare Pharmaceuticals Inc.
$35
Gilead Sciences, Inc.
$29
CARDIVA MEDICAL, INC.
$28
ARBOR PHARMACEUTICALS, INC.
$27
Biosense Webster, Inc.
$15
Baxter Healthcare
$15
iRhythm Technologies, Inc.
$14
Penumbra, Inc.
$13
Arbor Pharmaceuticals, Inc.
$13
G Medical Diagnostic Services, Inc.
$9
HeartFlow, Inc.
$3
Top 3 companies account for 30.3% of total payments
Associated products mentioned in payments ›
(CK4) MCOT · 3F · AMPLATZER Occluders · AZURE XT DR MRI SURESCAN · Assure WCD · Azure · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOFORM Septal Occluder · CARDIOMEMS · COBALT DR MRI SURESCAN · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Carto 3 System · Confirm Rx · Corlanor · DyeVert · ELIQUIS · ENSITE · ENTRESTO · EVKEEZA · Edarbi · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FLOWTRIEVER CATHETER · General - Therapies · Hillrom - Carnation Ambulatory Monitor · INVOKANA · Indigo System · Inpefa · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · MYCARELINK · MitraClip System · MyCareLink · NEXLETOL · NEXLIZET · NORTHERA · No Associated Product · None · ONPATTRO · OPTIMIZER · OPTOWIRE · Optimizer · Ozempic · PANTHERIS · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Reveal LINQ · S · SAPIEN 3 Ultra RESILIA · SQ-RX PULSE GENERATOR · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TYSABRI · VARITHENA · VERQUVO · VYEPTI · VYNDAMAX · VYNDAQEL · Varithena Administration Pack · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · XCOPRI · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $113 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
76
Per 100K population
55.3
County median income
$73,297
Nearest hospital
VILLAGES REGIONAL HOSPITAL, THE
6.2 mi
6.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gonzalez is a remote & cardiac specialist, with above-average Medicare volume (top 5% in FL), and high industry engagement (low-engagement, top 18%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gonzalez experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Gonzalez performed 1,228 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gonzalez receive payments from pharmaceutical companies?
Yes. Dr. Gonzalez received a total of $14,113 from 50 companies across 482 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gonzalez's costs compare to other cardiovascular diseases in The Villages?
Dr. Gonzalez's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gonzalez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in The Villages
Browse cardiovascular diseases in The Villages ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology